Fischer Medical’s Subsidiary Secures $6.5M TB Partnership in Indonesia
Filing Summary
Fischer Medical Ventures Limited, through its wholly owned subsidiary, Time Medical International Ventures (India) Pvt Ltd, has entered into a partnership with PT Pharmindo Rimpang Kokoh in Indonesia. The collaboration involves a pilot phase for the supply of portable, AI-powered X-ray systems aimed at tuberculosis eradication in the City of Jember. The contract, valued at approximately USD 6.5 million, is set for completion by March 2026. This initiative positions Fischer Medical as a strategic partner in Indonesia’s healthcare sector, enhancing its international presence.
Fischer Medical Ventures Limited, through its wholly owned subsidiary, Time Medical International Ventures (India) Pvt Ltd, has entered into a partnership with PT Pharmindo Rimpang Kokoh in Indonesia. The collaboration focuses on tuberculosis eradication in the City of Jember. The agreement involves the deployment of portable, AI-powered X-ray systems, marking a significant step in Fischer Medical’s international expansion.
The financial terms of the agreement specify a contract value of approximately USD 6.5 million. This amount covers the pilot phase of the project, which includes the supply and deployment of the X-ray systems. The financial arrangement underscores the scale and commitment of Fischer Medical Ventures to this international initiative.
The operational scope of the project involves the supply of portable, AI-powered X-ray systems. These systems are designed to aid in the detection and management of tuberculosis. The deployment is part of a pilot phase, which will see the installation of 250 units. This technological approach aims to enhance the efficiency and effectiveness of tuberculosis detection and management in the region.
The partnership with PT Pharmindo Rimpang Kokoh represents a strategic move for Fischer Medical Ventures. By collaborating with a local entity, Fischer Medical aims to leverage local expertise and infrastructure to facilitate the deployment of its technology. This initiative aligns with Indonesia’s public healthcare objectives, positioning Fischer Medical as a key player in the region’s healthcare sector.
The timeline for the project indicates that the order will be executed and delivered in tranches, with completion expected by March 2026. This phased approach allows for systematic deployment and integration of the X-ray systems, ensuring that the project meets its objectives within the stipulated timeframe.
PT Pharmindo Rimpang Kokoh is involved in the healthcare sector, focusing on innovative solutions to enhance medical services. The partnership with Fischer Medical Ventures aligns with its strategic priorities to integrate advanced technologies in healthcare delivery, particularly in the area of disease management and eradication.
Fischer Medical Ventures Limited is focused on expanding its presence in international markets through strategic partnerships and technological innovations. The company’s priorities include enhancing healthcare delivery through advanced medical technologies and establishing a strong foothold in emerging markets. This partnership in Indonesia is a testament to its commitment to global healthcare improvement.